Please provide your email address to receive an email when new articles are posted on . The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 ...

A multitude of studies link exposure to glyphosate and glyphosate-based herbicides to harmful impacts on women's reproductive ...

This bleeding is controlled by the hypothalamo-pituitary-ovarian axis ... anovulation, endometrial hyperplasia (a condition where the lining of the uterus becomes abnormally thick) and endometrial ...

Endometrial hyperplasia is a condition in which the lining of your uterus becomes too thick ... This is what prepares your uterus for a possible pregnancy. After the release of an egg from your ovary ...

Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a study published ...

More information: Zun-Jie Hu et al, Preservation of sexual function with blue laser vaporization in the treatment of benign prostatic hyperplasia: a prospective study, The Aging Male (2025). DOI ...

It is essential to rule out the risk of cancer in case of long persisting ovarian cysts, added Dr Sampada Dessai. Ovarian cysts are a common phenomenon that keep coming and going. When they do not ...

A standard diagnostic test for ovarian cancer is less effective in detecting the disease among Black and Native American women, according to a recent study published in JAMA Network Open. The test ...

Next-generation sequencing has enabled precision therapeutic approaches that have improved the lives of children with rare diseases. Congenital diarrhea and enteropathies (CODEs) are associated ...

A new drug is showing promise in tackling treatment-resistant ovarian cancer. Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve ...

The phase III ROSELLA study evaluated relacorilant in combination with nab-paclitaxel for treating patients with recurrent, platinum-resistant ovarian cancer. Data from the same showed that ...

The trial enrolled 381 platinum-resistant ovarian cancer subjects across sites in Argentina, Brazil, Canada, Europe, Australia, and South Korea. Credit: Chinnapong / Shutterstock. Corcept Therapeutics ...